Real-world experience of galcanezumab in the prevention of migraine in Spain: a systematic literature review.

ABSTRACT:

Introduction

In the context of migraine preventive therapy, new therapeutic modalities such as monoclonal antibodies targeting the calcitonin gene-related peptide receptor (CGRP) or ligand offer potential advantages over traditional preventive treatments.

Methods

This systematic literature review gathered recent real-world evidence from Spain on the use of galcanezumab, a CGRP-targeting treatment, in migraine patients. The review included observational studies in English or Spanish, published from August 2020 to August 2023, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Cochrane guidelines.

Results

A total of 29 publications involving 2,592 Spanish adult patients were identified, reporting relevant information on clinica

SUBMITTER: Pozo-Rosich P 

PROVIDER: S-EPMC11619139 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature